Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$7.57
52W Range
$2.14 - $12.90
50D Avg
$5.61
200D Avg
$5.02
Market Cap
$157.29M
Avg Vol (3M)
$175.85K
Beta
-0.05
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.